BIO Opposes Puerto Rico’s Newly Enacted Tax on Foreign Corporations

WASHINGTON, D.C. (Wednesday, October 27, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding Puerto Rico Law 154, which was enacted on Monday, October 25, 2010.

“The bioscience industry has remained a bright spot through one of the worst economic recessions on record. This is particularly true in Puerto Rico, where the bioscience industry accounts for over five percent of the employment base, providing stable, high-paying jobs. Without a doubt, the bioscience industry is crucial to the economic health of Puerto Rico.

“This is why BIO strongly opposes Law 154, a newly enacted four percent tax on foreign corporations that places an unprecedented and excessive burden on many of the biopharmaceutical and medical device companies located in Puerto Rico. This particularly ill-timed tax increase is a drastic change to longstanding tax law and is potentially detrimental to new and existing foreign investment in Puerto Rico.

“Puerto Rico has historically proven itself to be a center of excellence in attracting foreign investment and venture capital from innovative bioscience companies and investors. That is why it is particularly vexing that this legislation moved through both houses in a weekend, offering no time for public hearings, discussions or review of comments on the bill.

This new tax increase will profoundly affect the decision-making of foreign corporations as they consider whether to continue to do business and deploy their capital in Puerto Rico.”

Click here to view BIO’s letter to Puerto Rico Governor Fortuño


Upcoming BIO Events

Advanced Business Development Course
November 12-14, 2010
Munich, Germany

BIO-Europe International Partnering Conference
November 15-17, 2010
Munich, Germany

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
December 11-14, 2010
Honolulu, HI

BIO Asia International Partnering Conference
January 24-25, 2011
Tokyo, Japan

BIO CEO & Investor Conference
February 14-15, 2011
New York, NY

BIO-Europe Spring 2011
March 14-16, 2011
Milan, Italy

BIO Intellectual Property Counsels Committee Spring Conference and Committee Meeting
April 13-15, 2011
Seattle, WA

BIO International Convention
June 27-30, 2011
Washington, DC

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech Now, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtech Now.

For more information:

  • Visit
  • Follow us on Twitter @IAmBiotech
  • Join us on LinkedIn/MyBio
  • Become a fan at